Template:Cholecystitis Antibiotics: Difference between revisions
No edit summary |
No edit summary |
||
| Line 1: | Line 1: | ||
''Coverage is targeted at [[E. coli]], [[Enterococcus]], [[Bacteroides]], and [[Clostridium]] (anerobic) | ''Coverage is targeted at [[E. coli]], [[Enterococcus]], [[Bacteroides]], and [[Clostridium]] (anerobic)'' | ||
Most often isolated organisms are [[Escherichia coli]], [[Klebsiella pneumonia]], and anaerobes, especially [[Bacteroides | |||
fragilis]]; pathogenicity of [[Enterococci]] remains unclear and specific coverage is not routinely suggested for community-acquired infections'' | |||
====Uncomplicated Cholecystitis==== | ====Uncomplicated Cholecystitis==== | ||
*[[Ertapenem]] 1g IV once daily OR | *[[Ertapenem]] 1g IV once daily OR | ||
Revision as of 02:30, 3 April 2019
Coverage is targeted at E. coli, Enterococcus, Bacteroides, and Clostridium (anerobic) Most often isolated organisms are Escherichia coli, Klebsiella pneumonia, and anaerobes, especially [[Bacteroides fragilis]]; pathogenicity of Enterococci remains unclear and specific coverage is not routinely suggested for community-acquired infections
Uncomplicated Cholecystitis
- Ertapenem 1g IV once daily OR
- Metronidazole 500mg IV q8hrs PLUS
- Ciprofloxacin 400mg IV q12 hrs OR
- Levofloxacin 750mg IV q24hrs OR
- Ceftriaxone 1g IV q24hrs
Complicated
Complicated disease such as severe sepsis or hemodynamic instability
- Vancomycin 15-20mg/kg PLUS any of the following options
Options:
- Metronidazole 500mg IV q8hrs PLUS Ciprofloxacin 400mg IV q12hrs
- Piperacillin/Tazobactam 4.5g IV q8hrs
- Imipenem/Cilastin 500mg IV q6hrs
- Doripenem 500mg IV q8hrs
- Meropenem 1g IV q8hrs